Clyde S Crumpacker MD
Professor of Medicine, Beth Israel Deaconess Medical Center
Join to view full profile
330 Brookline Avenue/Dana 617Div Of Infectious DisBoston, MA 02215
Phone+1 617-667-5863
Dr. Crumpacker is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonResidency, Internal Medicine, 1970 - 1971
Boston University Medical CenterResidency, Internal Medicine, 1965 - 1967
Harvard Medical SchoolClass of 1965
Certifications & Licensure
MA State Medical License 1971 - 2015
Clinical Trials
- Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS
- A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure
- A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir
Publications & Presentations
PubMed
- A leap forward in vaccination - a molecular process of epigenetic silencing to the virus.Jielin Zhang, Philip Askenase, Clyde Crumpacker
Vaccine. 2026-10-03 - A Leap Forward in Vaccination - the Epigenetic Silencing of HIV by cVacc.Jielin Zhang, Philip Askenase, Clyde Crumpacker
Current HIV/AIDS Reports. 2026-07-08 - 2 citationsApproaches to pandemic prevention - the chromatin vaccine.Jielin Zhang, Philip Askenase, Rudolf Jaenisch, Clyde S Crumpacker
Frontiers in Immunology. 2023-01-01
Press Mentions
First Responders and Medical Staff Test Positive for Coronavirus. UW Doctors Not Getting MasksMarch 3rd, 2020
Grant Support
- Mechanisms Of Vascular Injury By HCMVNational Heart, Lung, And Blood Institute2002–2005
- Combination Therapy Involving Indinavir, Zidovudine, And Lamivudine In HIVNational Center For Research Resources1998–2000
- ACTG 320--Indinavir With OPEN Label Zidovudine And LamivudineNational Center For Research Resources1996–2000
- Pharmacokinetics And Antiretroviral Activity Study Of Oral Lobucavir In HIVNational Center For Research Resources1998–1999
- CMV Resistance, Viral Burden And Clinical ProgressionNational Institute Of Allergy And Infectious Diseases1997–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: